Ladprao General Hospital Public Company (LPH) Fair Value & Analysis
Healthcare · TH · Market cap 2.6B THB
Fair value as of: Jun 24, 2026
Analysis
Ladprao General Hospital Public Company (LPH) currently trades at 3.50 THB, while our model-based Fair Value estimate is 6.01 THB — implying the stock looks roughly 71.7% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. The company operates in two segments, Hospital and Scientific Testing & Inspection & Quality System Certification. It is involved in the operation of hospitals, specialty medical centers, facilities participating in the social security program, and health centers. The company also offers medical services and packages for various applications, including orthopedic, gastrointestinal and liver, beauty and laser, eyes disease, pediatric, hear, women's health, ENT, surgery, health checkup, brain and nervous system, rehabilitation medicine and physical therapy, dental, skin, internal medicine, lasik, diabetic and chronic wounds, and social security. In addition, it provides scientific analytical and diagnostic services for food and agricultural, pharmaceutical, and environmental covering product analysis, calibration of instruments, inspections, and certifications…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ladprao General Hospital Public Company (LPH) undervalued?
What is the fair value of LPH?
What is the quality score of LPH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.